{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:23:08Z","timestamp":1774894988362,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Introduction<\/jats:title>\n Hepatotoxicity monitoring is recommended for people living with HIV (PLHIV) enrolled on tuberculosis preventive treatment (TPT). Despite a 7.3% hepatotoxicity incidence reported in a multi-country study, implementation and adherence to hepatotoxicity monitoring remains low. We aimed at determining the prevalence, patients\u2019 and health workers\u2019 perceptions, and factors associated with non-adherence to hepatotoxicity monitoring among adult PLHIV receiving TPT at Mulago ISS clinic.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A sequential explanatory mixed methods study was carried among health workers and adult PLHIV enrolled on TPT between 2022 and 2023 at Mulago ISS clinic. The quantitative and qualitative components utilized a cross-sectional and an exploratory descriptive design respectively. A data abstraction tool was used to obtain quantitative data from files and electronic medical records of a systematic random sample of 390 patients. The qualitative study utilized interview guides to conduct in-depth audio recorded interviews for five patients and five health workers. Descriptive statistics and modified Poisson regression analyses were performed for the quantitative data. Deductive thematic analysis based on the health belief model was utilized for the qualitative data.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The prevalence of non-adherence to hepatotoxicity monitoring was 87.4% (95%CI: 83.7\u201390.4). The prevalence of non-adherence to hepatotoxicity monitoring was 85% lower in PLHIV that received primary TPT as compared to those on secondary TPT (aPR-0.15, 95% CI: 0.04\u20130.55). The qualitative findings revealed varied perceptions about non-adherence to hepatotoxicity monitoring that included awareness of associated risks, perceived benefits of monitoring, and confidence in taking action, while also identifying perceived barriers such as financial, knowledge and communication challenges.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The prevalence of non-adherence to hepatotoxicity monitoring was high within this pharmacovigilance sentinel site, given its clinical importance in HIV care and clear recommendations in the national HIV treatment guidelines. Health authorities should implement policies promoting hepatotoxicity monitoring in pharmacovigilance sentinel sites, especially for patients receiving secondary TPT, and allocate resources to support this initiative.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0345662","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:26:08Z","timestamp":1774891568000},"page":"e0345662","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence, perceptions and factors associated with non-adherence to hepatotoxicity monitoring among people living with HIV on tuberculosis preventive treatment at Mulago ISS clinic"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4441-4024","authenticated-orcid":true,"given":"Kevin","family":"Naturinda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Andia","family":"Biraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezekiel","family":"Mupere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8761-0359","authenticated-orcid":true,"given":"Anthony","family":"Muyunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Racheal Namutale","family":"Nalule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8376-6982","authenticated-orcid":true,"given":"Benard","family":"Owori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda Dorothy","family":"Akot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6084-4883","authenticated-orcid":true,"given":"Jovan","family":"Mugerwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Shem","family":"Kasambula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-3177","authenticated-orcid":true,"given":"Joseph","family":"Rubeihayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Kalyango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"pone.0345662.ref001","author":"WHO","year":"2024"},{"key":"pone.0345662.ref002","author":"WHO","year":"2018"},{"issue":"5","key":"pone.0345662.ref003","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hep.27710","article-title":"A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus\/acquired immune deficiency syndrome","volume":"61","author":"MW Sonderup","year":"2015","journal-title":"Hepatology"},{"key":"pone.0345662.ref004","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/1471-2458-12-454","article-title":"Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China","volume":"12","author":"S Wu","year":"2012","journal-title":"BMC Public Health"},{"key":"pone.0345662.ref005","author":"MOH","year":"2022"},{"issue":"1","key":"pone.0345662.ref006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/QAI.0000000000001641","article-title":"Hepatotoxicity during isoniazid preventive therapy and antiretroviral therapy in people living with HIV with severe immunosuppression: A secondary analysis of a multi-country open-label randomized controlled clinical trial","volume":"78","author":"M Ngongondo","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0345662.ref007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAI.0000000000002842","article-title":"High burden of adverse drug reactions to isoniazid preventive therapy in people living with HIV at 3 Tertiary Hospitals in Uganda: Associated factors","volume":"89","author":"SM Nanyonga","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0345662.ref008","first-page":"88","article-title":"Survey Sampling","volume":"10","author":"H Wiegand","year":"1968","journal-title":"Biometrische Zeitschrift"},{"issue":"1","key":"pone.0345662.ref009","first-page":"14","article-title":"Sample size calculation in medical studies","volume":"6","author":"MA Pourhoseingholi","year":"2013","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"7","key":"pone.0345662.ref010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/JCMA.0000000000000119","article-title":"The role of regular liver function monitoring in antituberculosis drug-induced liver injury","volume":"82","author":"T-E Chang","year":"2019","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"pone.0345662.ref011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0974-1208.97779","article-title":"Sample size estimation and power analysis for clinical research studies","volume":"5","author":"K Suresh","year":"2012","journal-title":"J Hum Reprod Sci"},{"key":"pone.0345662.ref012","article-title":"Annex 10: WHO clinical staging of HIV disease in adults, adolescents and children.","volume-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, W. H. Organization, Ed","author":"WHO","year":"2016"},{"issue":"1","key":"pone.0345662.ref013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"PN Newsome","year":"2018","journal-title":"Gut"},{"key":"pone.0345662.ref014","article-title":"Laboratory diagnostics performance in Uganda: A survey of test availability and constraints","author":"N Namuhani","year":"2024","journal-title":"Journal of Interventional Epidemiology and Public Health"},{"issue":"10","key":"pone.0345662.ref015","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1389200219666180523095355","article-title":"Models of drug induced liver injury (DILI) - Current issues and future perspectives","volume":"19","author":"L Kuna","year":"2018","journal-title":"Curr Drug Metab"},{"issue":"6","key":"pone.0345662.ref016","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver","year":"2019","journal-title":"J Hepatol"},{"key":"pone.0345662.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/HMER.S290542","article-title":"Anti-tuberculosis drug induced hepatotoxicity and associated factors among tuberculosis patients at selected hospitals, Ethiopia","volume":"13","author":"Y Molla","year":"2021","journal-title":"Hepat Med"},{"key":"pone.0345662.ref018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/hiv.13245","article-title":"Incidence of and risk factors for liver damage in patients with HIV-1 mono-infection receiving antiretroviral therapy","author":"H Huang","year":"2022","journal-title":"HIV Med"},{"key":"pone.0345662.ref019","first-page":"220","article-title":"HAART and hepatotoxicity","volume":"7","author":"D Ezhilarasan","year":"2017","journal-title":"Journal of Applied Pharmaceutical Science"},{"issue":"11","key":"pone.0345662.ref020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/JCMA.0000000000000605","article-title":"Hepatotoxicity, efficacy and completion rate between 3 months of isoniazid plus rifapentine and 9 months of isoniazid in treating latent tuberculosis infection: a systematic review and meta-analysis","volume":"84","author":"S-Y Tseng","year":"2021","journal-title":"J Chin Med Assoc"},{"issue":"7","key":"pone.0345662.ref021","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/09540121.2018.1563280","article-title":"Compliance with laboratory monitoring guidelines in outpatient HIV care: a qualitative study in the Netherlands","volume":"31","author":"DCM Toxopeus","year":"2019","journal-title":"AIDS Care"},{"issue":"1","key":"pone.0345662.ref022","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1186\/s12889-022-13674-z","article-title":"Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study","volume":"22","author":"P Lubega","year":"2022","journal-title":"BMC Public Health"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:26:14Z","timestamp":1774891574000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345662"}},"subtitle":[],"editor":[{"given":"Vandana","family":"Dabla","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345662","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}